Canada's Drug Agency | Homepage

We are Canada's Drug Agency

Learn more

Canada’s Drug Agency Announces Recipients of Funding to Enhance Rare Disease Registries

Read more about Canada’s Drug Agency Announces Recipients of Funding to Enhance Rare Disease Registries

New Flexible Service Through Our Scientific Advice Program

Read more about New Flexible Service Through Our Scientific Advice Program

New Guidance Aims to Inform Aging-in-Place Initiatives

Read more about New Guidance Aims to Inform Aging-in-Place Initiatives

Featured Reports

All Reports
All Reports

Powering evidence-informed drug and health technology decisions for sustainable, world-class health care for all

We are experts at finding, interpreting, and assembling the best available information, and we know that evidence is the foundation of good decision-making.

Learn More

A National Capital Region’s top employer

We are proud and excited to share that our organization has been named one of the National Capital Region's top employers for 2024.

Read More

Latest News

All News

A Roadmap for Patient and Disease Registries: Linking Health Data to Enhance Rare Disease Decision-Making

Canada’s Drug Agency, with support from our health system partners including ICES and Health Data Research Network Canada (HDRN), has published a new ...

Canada’s Drug Agency Announces Recipients of Funding to Enhance Rare Disease Registries

Canada’s Drug Agency is pleased to announce the successful applicants from our 2024 Request for Proposals (RFP) to support the enhancement of rare ...

New Flexible Service Through Our Scientific Advice Program

Drug sponsors can now request a flexible service through our Scientific Advice program that can include a shorter time frame. For Scientific Advice ...

New Guidance Aims to Inform Aging-in-Place Initiatives

Canada’s Drug Agency has released new guidance around aging in place. This guidance is intended to help health systems address Canada’s demographic ...

We’re Officially Launching Canada’s Drug Agency

Today’s the day: we are officially Canada’s Drug Agency. We are expanding on our existing mandate and functions — which span drugs, medical devices ...

Understanding the Rare Disease Registries Landscape in Canada

Canada’s Drug Agency has published a national inventory of rare disease registries (RDRs) that includes both registries in Canada and international ...
All News

Canada’s Drug Agency

Canada’s Drug Agency is a pan-Canadian health organization.

Created and funded by Canada’s federal, provincial, and territorial governments, we’re responsible for driving better coordination, alignment, and public value within Canada’s drug and health technology landscape.

We provide Canada’s health system leaders with independent evidence and advice so they can make informed drug, health technology, and health system decisions, and we collaborate with national and international partners to enhance our collective impact. 

Upcoming Events

All Events

CORD Fall 2024 Rare Diseases Conference

-
all day
Read More CORD Fall 2024 Rare Diseases Conference

12th Annual Data Analytics for Healthcare Summit

-
all day
Read More 12th Annual Data Analytics for Healthcare Summit
All Events
postcard

Canada’s Drug Agency recognizes the traditional territories, rights, and diversity of all First Nations, Inuit, and Métis communities across Canada. Indigenous Peoples have been, and continue to be, excluded from and harmed by Canada’s health care systems. In the spirit of reconciliation, we are committed to addressing these inequities alongside Indigenous communities.